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Abstract
Introduction Tick-borne encephalitis (TBE) presents without
neurologic symptoms in 19% in children less than 16 years in
Switzerland (2000–2008). In these cases, fever can be the only
leading manifestation.
Case series We report on four hospitalised children who
had TBE and presented as fever without localising signs
(FWLS) between 2000 and 2008 in an endemic area in
Switzerland.
Conclusion TBE infection has to be considered in the
differential diagnosis of FWLS in endemic areas.
Foremost, FWLS characterised by a biphasic fever course
and accompanied by headache in patients in a reduced
general condition. Affirming that in patients presenting
as FWLS also cases of TBE are contained, this disease is
underreported.
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Introduction
Tick-borne encephalitis (TBE) is caused by TBE virus, a
neurotropic flavivirus which causes meningitis, enceph-
alitis and/or myelitis. In approximately one third of
patients infected, the second phase of disease develops,
characterised by symptoms and signs of meningitis or
meningoencephalitis, fever and/or flu-like symptoms
[1, 2]. Meningeal signs usually occur, but may not be
pronounced [1]. Children less than 16 years with TBE
were reported in up to 19% without any presence of
neurologic symptoms (e.g. neck stiffness, altered state of
consciousness, seizures) to the nationwide mandatory
notification system in Switzerland during 2000 and
2008.
TBE is endemic in Switzerland with risk areas in the
northeast, and therefore, TBE is a mandatory reportable
disease in Switzerland. Since the early 1990s, there has
been a steady increase of TBE. In 2006, the highest
number of cases in recorded history was reported. The
epidemiology of TBE is closely related to the persons
living in endemic areas for whom an increased risk of
exposure is present and to the ecology and biology of
ticks. Since 2007, the cases reported annually are about
at the same level as before 2006. As a result, Swiss
vaccination policy was amended in 2006; the new
recommendations advised vaccinating adults and children
6 years of age in endemic areas [2].
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Materials and methods
Between 2000 and 2008, all cases of TBE occurring in
children less than 16 years were retrospectively assessed at
our department. The catchment area is one part of canton
Zurich, which is a high-risk region for TBE in Switzerland.
In all these cases, those with fever as the leading manifestation
were further analysed.
The case definition included fever without localising
signs (FWLS), cerebrospinal fluid (CSF) pleocytosis and
positive TBE serology in blood, i.e. IgG and IgM anti-
bodies directed against TBE virus (FSME ELISA, Genzyme
Virotech GmbH, Rüsselsheim, Germany; sensitivity for
IgG and IgM >99.8%, specificity for IgG 95.6% and
IgM >99.8%).
The quest for TBE infection in children with FWLS living
in an endemic area for TBE was prompted because of clinical
features in addition to FWLS, which included a biphasic fever
course, headache and a reduced general condition.
Results
At our department, 26 patients (median age 6.0 years, range
3–16) were tested for TBE between 2000 and 2008,
whereof ten patients presented as FWLS.
Five patients had a positive TBE serology in blood, i.e.
serum antibodies directed against TBE virus were present
in positive titres.
Table 1 TBE presenting as FWLS, 2000–2008, Department of Paediatrics, Triemli Hospital Zurich
Clinical and laboratory features
Patient Age
(years)
Gender Season Symptoms CSF Inflammatory
parameters
Results of
serologic
testing for
TBE
Hospital
stay
(days)
Total cell
count
(cells/μl)
Mononuclear
cells
(cells/μl)
Protein
(g/l)
Glucose
(mmol/l)
WBC
(109/l)
CRP
(mg/l)
IgM IgG
1 4 M November Fever (40.0°C),
headache, vomiting
100 27 0.30 3.0 24.8 69.7 + + 7
2 7 M June Fever (39.5°C),
headache, vomiting
67 53 0.51 2.9 11.9 3.0 + + 7
3 4 F July Fever (38.5°C),
headache, vomiting
68 57 0.30 4.1 25.9 4.9 + + 2
4 9 M June Fever (39.0°C),
headache
164 51 0.58 2.9 34.5 40.5 + + 7
CSF cerebrospinal fluid, WBC white blood cell count, CRP C-reactive protein
Table 2 Recorded cases of TBE in Switzerland, 2000–2008,
notifications by age and presence of neurologic symptoms
Total Neurologic
symptoms, n (%)
Without neurologic
symptoms, n (%)
All ages 1,177 1,006 (85) 171 (15)
<16 years 192 156 (81) 36 (19)
<6 years 34 28 (82) 6 (18)
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Fig. 1 Recorded cases of TBE in Switzerland, 2000–2008, annual
notifications
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The case definition with FWLS and cerebrospinal fluid
pleocytosis was fulfilled in four of these five hospitalised
children (three males, one female). Only one patient with
TBE expressed meningeal signs (neck stiffness) and was
excluded from the study.
The median age was 5.8 years (range 4–9; Table 1). All
patients presented with fever (38.5–40.0°C), with a charac-
teristic biphasic course. There were no signs of meningoen-
cephalitis. Clinical severity of the acute hospital course was
given on the basis of reduced general condition and
headache (all patients), as well as additional vomiting (three
patients). No patient was immunised with TBE vaccine. One
patient recalled a tick bite. CSF analysis showed pleocytosis
of 84 cells/µl (range 67–164) with 52 mononuclear (27–57).
CSF protein and glucose were 0.41 g/l (0.30–0.58) and
2.9 mmol/l (2.9–4.1), respectively. The peripheral white
blood cell count was 25.3×109/l (11.9–34.5) with normal
distribution; C-reactive protein was 22.7 mg/l (3–69.7).
The median length of hospital stay was 7 days (2–7). No
seizures or neurological after-effects occurred. The patients
recovered completely and were discharged without sequelae.
Conclusion
The aim of this study was to evaluate cases of TBE
presenting as FWLS, especially without signs of meningo-
encephalitis. The four presented patients developed only
FWLS during TBE virus infection.
Due to the retrospective data collection, we cannot make
a statement about total cases presenting as FWLS to our
emergency department in the period above because we do
not document the initially working hypothesis FWLS.
Therefore, we can only mention how many patients with
FWLS were tested for TBE (four positive and six negative),
but we cannot declare how many were not tested at all.
Thus, further studies involving more cases with a prospective
data collection are needed.
Based on our data, the emphasis in managing children
with FWLS in endemic areas should be on diagnosing
TBE; foremost, FWLS characterised by a biphasic fever
course and accompanied by headache in patients in a
reduced general condition. Fever can be the only leading
manifestation of TBE. TBE infection therefore has to be
considered in the differential diagnosis of FWLS.
Twenty percent of febrile children have FWLS [3]. The
incidence for TBE in Switzerland in 2008 was 1.5/105/year,
in endemic areas 6/105/year [2]. Affirming that in patients
presenting as FWLS also cases of TBE are contained, this
disease is underreported. The approach to perform a lumbar
puncture (to demonstrate aseptic meningitis) and blood
serology (for case inclusion of TBE) evaluating children
with FWLS in endemic areas can result in an increase in
mandatory TBE notifications ‘without neurologic symptoms’
(Table 2) and finally in an increase in the incidence for TBE
(Fig. 1).
In conclusion, making an early diagnosis of TBE in children
with FWLS is essential: first, to separate from several other
infections which can cause aseptic meningitis and encephalitis,
and second, therefore to minimise and prevent ancillary testing
and antibiotic and/or antiviral treatment, respectively.
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